Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: An angioscopic study
- 1 February 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 117 (2), 275-281
- https://doi.org/10.1016/0002-8703(89)90769-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Proteose peptone enhances production of tissue-type plasminogen activator from human diploid fibroblastsBiochemical and Biophysical Research Communications, 1988
- Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.Radiology, 1986
- Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high dose urokinaseThe American Journal of Surgery, 1986
- Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.Circulation, 1986
- Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.Circulation, 1984
- Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarctionAmerican Heart Journal, 1981
- Intracoronary thrombolysis in evolving myocardial infarctionAmerican Heart Journal, 1981